Last reviewed · How we verify
Epinephrin 0.02
Epinephrin 0.02, marketed by Kasr El Aini Hospital, is an established product in the pharmaceutical market with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established market presence and the protection offered by its patent. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Epinephrin 0.02 |
|---|---|
| Also known as | adrenaline |
| Sponsor | Kasr El Aini Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation (PHASE1)
- Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (PHASE1, PHASE2)
- Effect of Hypochlorous Acid-containing Mouthwash on Healing After Impacted Wisdom Tooth Surgery (NA)
- Bilateral Bi-level Erector Spine Plane Block as a Component of General Anesthesia in Surgical Correction of Spinal Deformations (NA)
- Anesthetic Approaches for Dacryocystorhinostomy Surgery: The Effect of Adding Local Anesthesia to General Inhalational Anesthesia (NA)
- Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery (PHASE4)
- ERECTOR SPINE PLANE BLOCK VERSUS LOCAL INFILTRATION ANAESTHESIA FOR TRANSFORAMINAL PERCUTANEOUS ENDOSCOPIC DISCECTOMY (NA)
- Terlipressin for Refractory Septic Shock (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epinephrin 0.02 CI brief — competitive landscape report
- Epinephrin 0.02 updates RSS · CI watch RSS
- Kasr El Aini Hospital portfolio CI